SAR 14.52
(-1.89%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.41 Billion | 454.12 Million | 66.8 Million | -1.46 Billion | -1.74 Billion | 2.16 Billion |
Net Income | 610.75 Million | 588.38 Million | 135.44 Million | 19.37 Million | 312.38 Million | 521.85 Million |
Depreciation & Amortization | 50.24 Million | 50.18 Million | 48.9 Million | 56.23 Million | 55.65 Million | 78.35 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.11 Billion | -59.32 Million | -32.95 Million | -1.5 Billion | -2.06 Billion | 1.54 Billion |
Other non-cash items | -355.96 Million | -125.11 Million | -84.58 Million | -31.44 Million | -48.57 Million | 16.14 Million |
Investing Cash Flow | -1.16 Billion | -14.25 Million | -8.97 Million | -4.37 Million | -329.53 Million | -20.99 Million |
Investments in PPE | -19.32 Million | -21.23 Million | -6.66 Million | -2.63 Million | -6.29 Million | -20.34 Million |
Acquisitions | 13.66 Million | 11.77 Million | -1.84 Million | -458 Thousand | -320 Million | - |
Investment purchases | -1.15 Billion | -80.93 Million | -2.39 Million | -1.74 Million | -323.24 Million | -648 Thousand |
Sales/Maturities of investments | 1.14 Billion | 87.11 Million | 2.39 Million | 1.74 Million | 323.24 Million | - |
Other Investing Activities | -1.14 Billion | -10.97 Million | -460 Thousand | -1.28 Million | -3.24 Million | -649 Thousand |
Financing Cash Flow | -731.57 Million | 1.33 Billion | -836.06 Million | 2.44 Billion | 1.11 Billion | -395.63 Million |
Debt repayment | -722.09 Million | -1.33 Billion | -836.06 Million | -2.44 Billion | -1.11 Billion | -144.36 Million |
Dividends payments | - | - | - | - | - | -540 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -9.48 Million | 2.67 Billion | -836.06 Million | 4.89 Billion | 2.23 Billion | 144.36 Million |
Accounts receivables | 572.39 Million | 1.31 Billion | -1.12 Billion | -670.16 Million | 757.35 Million | -707.55 Million |
Accounts payables | 202.43 Million | -322.47 Million | 1.78 Billion | 433.68 Million | -86.57 Million | 348.21 Million |
Inventory | 339.95 Million | -1.05 Billion | -694.3 Million | -1.26 Billion | -2.73 Billion | 1.9 Billion |
Other working capital | -3.38 Million | -4.38 Million | -2.4 Million | -6.27 Million | -2.14 Million | -359.9 Million |
Cash at beginning of period | 5.92 Billion | 4.15 Billion | 4.93 Billion | 3.95 Billion | 4.9 Billion | 3.15 Billion |
Cash at end of period | 5.44 Billion | 5.92 Billion | 4.15 Billion | 4.93 Billion | 3.95 Billion | 4.9 Billion |
Capital Expenditure | -19.32 Million | -21.23 Million | -6.66 Million | -2.63 Million | -6.29 Million | -20.34 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -479.02 Million | 1.77 Billion | -778.23 Million | 981.64 Million | -953.47 Million | 1.74 Billion |
Free Cash Flow | 1.39 Billion | 432.89 Million | 60.13 Million | -1.46 Billion | -1.74 Billion | 2.14 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 165.96 Million | 153.59 Million | 194.74 Million | 610.75 Million | 155.8 Million | 150.23 Million |
Depreciation & Amortization | 13.48 Million | 13.45 Million | 13.41 Million | 50.24 Million | 13.38 Million | 12.07 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -257.53 Million | -491.05 Million | -119.09 Million | 1.11 Billion | -440.05 Million | 240.72 Million |
Other non-cash items | 282.15 Million | 523.45 Million | -196.27 Million | -355.96 Million | -64.78 Million | -50.09 Million |
Investing Cash Flow | -1.47 Million | -1.85 Million | -15.69 Million | -1.16 Billion | -1.99 Million | -39.51 Million |
Investments in PPE | -1.47 Million | -1.06 Million | -4.59 Million | -19.32 Million | -2.07 Million | -8.2 Million |
Acquisitions | - | -788 Thousand | 228 Thousand | 13.66 Million | 76 Thousand | -31.3 Million |
Investment purchases | - | - | -11.33 Million | -1.15 Billion | - | -31.31 Million |
Sales/Maturities of investments | - | - | 11.1 Million | 1.14 Billion | - | 31.31 Million |
Other Investing Activities | - | - | -11.1 Million | -1.14 Billion | 75.99 Thousand | -9000.00 |
Financing Cash Flow | -50.84 Million | 529.53 Million | -136.75 Million | -731.57 Million | 1.87 Billion | -11.51 Million |
Debt repayment | -47.4 Million | -530.01 Million | -127.27 Million | -722.09 Million | -1.87 Billion | -11.51 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.43 Million | - | -136.75 Million | - | 1.87 Billion | -11.51 Million |
Accounts receivables | -197.76 Million | -236.17 Million | 463.61 Million | 572.39 Million | -557.99 Million | 41.34 Million |
Accounts payables | 291.38 Million | 34.21 Million | 203.56 Million | 202.43 Million | 78.39 Million | 521.37 Million |
Inventory | -350.55 Million | -288.9 Million | -786.02 Million | 339.95 Million | 39.53 Million | -321.99 Million |
Other working capital | -599 Thousand | -190 Thousand | -246 Thousand | -3.38 Million | -660 Thousand | -2.2 Million |
Cash at beginning of period | 5.65 Billion | 5.44 Billion | 5.7 Billion | 5.92 Billion | 4.16 Billion | 3.86 Billion |
Cash at end of period | 5.52 Billion | 5.65 Billion | 5.44 Billion | 5.44 Billion | 5.7 Billion | 4.16 Billion |
Capital Expenditure | -1.47 Million | -1.06 Million | -4.59 Million | -19.32 Million | -2.07 Million | -8.2 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -132.14 Million | 209.35 Million | -259.66 Million | -479.02 Million | 1.54 Billion | 301.9 Million |
Free Cash Flow | -81.3 Million | -319.39 Million | -111.81 Million | 1.39 Billion | -337.72 Million | 344.73 Million |
8022
PATH
PRIM
MED
ICGUF
4951